PER2 and breast carcinoma: Interestingly, the CRY1/2 inhibitor KS15 has been reported to reduce MCF-7 cell growth and increase chemosensitivity in human breast cancer cells, possibly via the drug-induced elevation of PER2, a tumor suppressor clock protein95.